Edgar Romero-Sandoval to Neuralgia
This is a "connection" page, showing publications Edgar Romero-Sandoval has written about Neuralgia.
Connection Strength
1.838
-
Romero-Sandoval EA. Peripheral benzodiazepine receptors: are they potential biomarkers for glial activation in pain states? Eur J Pain. 2013 May; 17(5):635-7.
Score: 0.439
-
Landry RP, Martinez E, DeLeo JA, Romero-Sandoval EA. Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain. J Pain. 2012 Sep; 13(9):836-48.
Score: 0.418
-
Ndong C, Landry RP, DeLeo JA, Romero-Sandoval EA. Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain. Mol Pain. 2012 Apr 27; 8:34.
Score: 0.410
-
Romero-Sandoval EA. Depression and pain: does ketamine improve the quality of life of patients in chronic pain by targeting their mood? Anesthesiology. 2011 Oct; 115(4):687-8.
Score: 0.394
-
Cash MC, Cunnane K, Fan C, Romero-Sandoval EA. Mapping cannabis potency in medical and recreational programs in the United States. PLoS One. 2020; 15(3):e0230167.
Score: 0.177